NeoGenomics, Inc. (NEO) vs Ovid Therapeutics Inc. (OVID)
A side-by-side comparison of NeoGenomics, Inc. and Ovid Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NEO
NeoGenomics, Inc.
$16.72HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
OVID
Ovid Therapeutics Inc.
$2.39HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — NEO vs OVID
growth of $100 · dividends reinvested · last 9yNEO +151.3% (+10.8%/yr)OVID -80.9% (-16.8%/yr)NEO compounded faster over this window
Log scale — wide-divergence pair
NEO OVID
NEO vs OVID: by the numbers
- •OVID is the larger company ($446M vs $429M market cap).
- •Both run net losses; NEO's is the smaller (-6.77% vs -2178.90% net margin).
- •NEO grew revenue faster over the past five years (9.41% vs -62.76% CAGR).
Metrics side by side
Valuation
| Metric | NEO | OVID |
|---|---|---|
| Forward P/E | 91.47 | N/A |
| P/S ratio | 0.56 | 281.81 |
| P/B ratio | 0.55 | 2.13 |
Profitability
| Metric | NEO | OVID |
|---|---|---|
| Gross margin | 42.92% | 100.00% |
| Operating margin | -8.63% | -585.20% |
| Net margin | -6.77% | -2178.90% |
| ROE | -6.60% | -16.43% |
| ROIC | -5.29% | -26.29% |
Growth (annualized)
| Metric | NEO | OVID |
|---|---|---|
| Revenue CAGR (5Y) | 9.41% | -62.76% |
| Total return CAGR (5Y) | -15.14% | -6.98% |
Frequently asked
- Which has grown faster, NEO or OVID?
- Over the past five years, NEO grew revenue faster — NEO at a 9.41% CAGR versus OVID at -62.76%.
- How have NEO and OVID total returns compared?
- Over the past 5 years, NEO delivered -15.14% and OVID delivered -6.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.